495 related articles for article (PubMed ID: 12239248)
1. Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection.
Sester M; Sester U; Gärtner BC; Girndt M; Meyerhans A; Köhler H
J Am Soc Nephrol; 2002 Oct; 13(10):2577-84. PubMed ID: 12239248
[TBL] [Abstract][Full Text] [Related]
2. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
3. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
[TBL] [Abstract][Full Text] [Related]
4. Rapid T cell repopulation after rabbit anti-thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus.
Havenith SH; Remmerswaal EB; Bemelman FJ; Yong SL; van Donselaar-van der Pant KA; van Lier RA; Ten Berge IJ
Clin Exp Immunol; 2012 Sep; 169(3):292-301. PubMed ID: 22861369
[TBL] [Abstract][Full Text] [Related]
5. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation.
Sester M; Sester U; Gärtner B; Heine G; Girndt M; Mueller-Lantzsch N; Meyerhans A; Köhler H
Transplantation; 2001 May; 71(9):1287-94. PubMed ID: 11397964
[TBL] [Abstract][Full Text] [Related]
6. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.
Gratama JW; van Esser JW; Lamers CH; Tournay C; Löwenberg B; Bolhuis RL; Cornelissen JJ
Blood; 2001 Sep; 98(5):1358-64. PubMed ID: 11520783
[TBL] [Abstract][Full Text] [Related]
7. Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.
Shlobin OA; West EE; Lechtzin N; Miller SM; Borja M; Orens JB; Dropulic LK; McDyer JF
J Immunol; 2006 Feb; 176(4):2625-34. PubMed ID: 16456025
[TBL] [Abstract][Full Text] [Related]
8. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient.
Benz C; Holz G; Michel D; Awerkiew S; Dries V; Stippel D; Goeser T; Busch DH
Transplantation; 2003 Mar; 75(5):724-7. PubMed ID: 12640316
[TBL] [Abstract][Full Text] [Related]
9. Properties of CD4(+) T cells in human cytomegalovirus infection.
Gamadia LE; Rentenaar RJ; van Lier RA; ten Berge IJ
Hum Immunol; 2004 May; 65(5):486-92. PubMed ID: 15172448
[TBL] [Abstract][Full Text] [Related]
10. Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia.
Chen JS; Li LS; Cheng DR; Ji SM; Sun QQ; Cheng Z; Wen JQ; Sha GZ; Liu ZH
Transplant Proc; 2009 Jun; 41(5):1639-42. PubMed ID: 19545698
[TBL] [Abstract][Full Text] [Related]
11. Rapid reconstitution of CMV-specific T-cells after stem-cell transplantation.
Widmann T; Sester U; Schmidt T; Gärtner BC; Schubert J; Pfreundschuh M; Sester M
Eur J Haematol; 2018 Jul; 101(1):38-47. PubMed ID: 29652096
[TBL] [Abstract][Full Text] [Related]
12. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.
Gamadia LE; Remmerswaal EB; Weel JF; Bemelman F; van Lier RA; Ten Berge IJ
Blood; 2003 Apr; 101(7):2686-92. PubMed ID: 12411292
[TBL] [Abstract][Full Text] [Related]
13. Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.
Pipeling MR; West EE; Osborne CM; Whitlock AB; Dropulic LK; Willett MH; Forman M; Valsamakis A; Orens JB; Moller DR; Lechtzin N; Migueles SA; Connors M; McDyer JF
J Immunol; 2008 Jul; 181(1):546-56. PubMed ID: 18566421
[TBL] [Abstract][Full Text] [Related]
14. Specific Immunity to Cytomegalovirus in Pediatric Cardiac Transplantation.
Jacobsen MC; Manunta MDI; Pincott ES; Fenton M; Simpson GL; Klein NJ; Burch M
Transplantation; 2018 Sep; 102(9):1569-1575. PubMed ID: 29509573
[TBL] [Abstract][Full Text] [Related]
15. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
Widmann T; Sester U; Gärtner BC; Schubert J; Pfreundschuh M; Köhler H; Sester M
PLoS One; 2008; 3(11):e3634. PubMed ID: 18982061
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
[TBL] [Abstract][Full Text] [Related]
17. Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive but not seronegative donors.
Hoegh-Petersen M; Roa L; Liu Y; Zhou F; Ugarte-Torres A; Louie P; Fonseca K; Khan F; Russell JA; Storek J
Cytotherapy; 2012 Feb; 14(2):194-204. PubMed ID: 22149135
[TBL] [Abstract][Full Text] [Related]
18. Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS.
Kaur A; Kassis N; Hale CL; Simon M; Elliott M; Gomez-Yafal A; Lifson JD; Desrosiers RC; Wang F; Barry P; Mach M; Johnson RP
J Virol; 2003 May; 77(10):5749-58. PubMed ID: 12719568
[TBL] [Abstract][Full Text] [Related]
19. Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.
Shabir S; Kaul B; Pachnio A; Banham GD; Smith H; Chand S; Jham S; Harper L; Ball S; Rahbar A; Söderberg-Nauclér C; Moss P; Borrows R
J Am Soc Nephrol; 2013 Oct; 24(10):1698-708. PubMed ID: 23847277
[TBL] [Abstract][Full Text] [Related]
20. CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.
Sund F; Lidehäll AK; Claesson K; Foss A; Tötterman TH; Korsgren O; Eriksson BM
Clin Transplant; 2010; 24(3):401-9. PubMed ID: 19222507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]